drugset / Trial / NCT00562718

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

NCT00562718 ↗

Phase 2 Completed 50 enrolled University of Texas Southwestern Medical Center
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high energy x-rays to kill tumor cells. Capecitabine may also make tumor cells more sensitive to radiation therapy. Giving radiation together with capecitabine after surgery may kill any remaining tumor cells. PURPOSE: This phase II trial is studying the side effects and how well giving capecitabine together with radiation therapy works in treating patients with nonmetastatic breast cancer.

Timeline

Start
2004-09
Primary completion
2009-09
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — Oral

Indications